ADVANCING SCIENCE. ENHANCING VISION. - Trademark Details
Status: 700 - Registered
Serial Number
85318930
Registration Number
4834268
Word Mark
ADVANCING SCIENCE. ENHANCING VISION.
Status
700 - Registered
Status Date
2015-10-20
Filing Date
2011-05-12
Registration Number
4834268
Registration Date
2015-10-20
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2015-08-04
Attorney Name
Law Office Assigned Location Code
M90
Employee Name
BELL, MARLENE D
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Goods and Services
Chemical preparations and substances for use in the manufacture of pharmaceutical products and medicines; diagnostic medical reagents, chemicals and biological materials, namely, antigen and diagnostic kits consisting primarily of monoclonal and/or polyclonal antibodies, buffers, and reagents for medical laboratory use in disease testing
Goods and Services
Pharmaceutical preparations and substances for treatment of diseases and disorders, namely, ophthalmic and visual disorders, vascular and cardiovascular disorders, cardiac diseases, diabetes, stroke, inflammation, hypertension, pulmonary hypertension, edema, immune system disorders, immune system related disorders, eye diseases, blood disorders, thrombotic diseases and cancer; veterinary preparations for treatment of diseases and disorders in mammalians, namely, ophthalmic and visual disorders, vascular and cardiovascular disorders, cardiac diseases, stroke, inflammation, hypertension, pulmonary hypertension, edema, immune system disorders, immune system related disorders, eye diseases, blood disorders, thrombotic diseases and cancer; sanitary preparations for medical purposes; dietetic foods adapted for medical use, food for babies; medical plasters; material for stopping teeth, dental wax; disinfectants for medical instruments, for hygienic purposes, and for use in medical surgery procedures; preparations for destroying vermin; fungicides, herbicides; biopharmaceutical preparations, namely, anticoagulants, anti angiogenic drugs, anticancer drugs, cardiovascular drugs, protease enzymes, protease inhibitors, antibodies, plasmins, truncated plasmins, microplasmins, plasminogens, truncated plasminogens, microplasminogens, plasminogen activators, staphylokinases for the treatment diseases and disorders, namely, ophthalmic and visual disorders, vascular and cardiovascular disorders, cardiac diseases, stroke, inflammation, hypertension, pulmonary hypertension, edema, immune system disorders, immune system related disorders, eye diseases, blood disorders, thrombotic diseases and cancer
Goods and Services
Scientific and technological services, namely, scientific research and design of new products in the field of ophthalmic, visual, vascular, cardiac, inflammation, hypertension, immune system, blood and cancer disease and disorder detection, in the field of ophthalmic, visual, vascular, cardiac, inflammation, hypertension, immune system, blood and cancer disease and disorder prevention, and in the field of ophthalmic, visual, vascular, cardiac, inflammation, hypertension, immune system, blood and cancer disease and disorder treatment; industrial research analysis and product research services in the field of ophthalmic, visual, vascular, cardiac, inflammation, hypertension, immune system, blood and cancer disease and disorder detection, in the field of ophthalmic, visual, vascular, cardiac, inflammation, hypertension, immune system, blood and cancer disease and disorder prevention and in the field of ophthalmic, visual, vascular, cardiac, inflammation, hypertension, immune system, blood and cancer disease and disorder treatment; pharmaceutical, biopharmaceutical, medical, biomedical, biological, biochemical, toxicological and clinical research, namely, conducting clinical trials for others or providing consultancy services to others for conducting clinical trials, and product development of diagnostic tests and kits, biopharmaceutical preparations and drugs, and medicines; biopharmaceutical product evaluation; biological, biochemical, pharmaceutical, medical, toxicological and clinical research, namely, conducting clinical trials for others or providing consultancy services to others for conducting clinical trials, and scientific research for medical purposes in the treatment of ophthalmic, visual, vascular, cardiac, inflammation, hypertension, immune system, blood and cancer diseases and disorders; development services in the field of new biopharmaceutical drugs, preparations and medicines for ophthalmic, vascular and cancer pathologies
Classification Information
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2011-05-17
Primary Code
042
Current Trademark Owners
Trademark Owner History
Party Name
Party Type
31 - 1st New Owner Entered After Registration
Legal Entity Type
32
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
99 - Other (naamloze vennootschap (nv)).
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
99 - Other (naamloze vennootschap (nv)).
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
99 - Other (naamloze vennootschap (nv)).
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Clifford D. Hyra
Address
Please log in with your Justia account to see this address.
Foreign Application Information
Filing Date | Application Number | Country | Foreign Priority Claim In |
2012-03-27 | 009907676 | EM | False |
Trademark Events
Event Date | Event Description |
2011-05-16 | NEW APPLICATION ENTERED IN TRAM |
2011-05-17 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2011-08-29 | ASSIGNED TO EXAMINER |
2011-09-03 | NON-FINAL ACTION WRITTEN |
2011-09-03 | NON-FINAL ACTION E-MAILED |
2011-09-03 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2011-12-08 | ASSIGNED TO EXAMINER |
2012-01-04 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2012-01-04 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2012-01-04 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2012-01-25 | FINAL REFUSAL WRITTEN |
2012-01-25 | FINAL REFUSAL E-MAILED |
2012-01-25 | NOTIFICATION OF FINAL REFUSAL EMAILED |
2012-07-06 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
2012-07-06 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2012-07-06 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2012-07-17 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2012-07-31 | ASSIGNED TO LIE |
2012-08-03 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
2012-08-22 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2012-09-11 | PUBLISHED FOR OPPOSITION |
2012-09-11 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2012-11-06 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
2013-05-02 | TEAS EXTENSION RECEIVED |
2013-05-02 | EXTENSION 1 FILED |
2013-05-02 | EXTENSION 1 GRANTED |
2013-05-04 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2013-11-04 | TEAS EXTENSION RECEIVED |
2013-11-04 | EXTENSION 2 FILED |
2013-11-04 | EXTENSION 2 GRANTED |
2013-11-06 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2014-05-05 | TEAS EXTENSION RECEIVED |
2014-05-05 | EXTENSION 3 FILED |
2014-05-05 | EXTENSION 3 GRANTED |
2014-05-07 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2014-10-31 | TEAS EXTENSION RECEIVED |
2014-10-31 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
2014-12-03 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
2014-10-31 | EXTENSION 4 FILED |
2014-12-04 | EXTENSION 4 GRANTED |
2014-12-05 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2015-04-29 | TEAS PETITION TO AMEND BASIS RECEIVED |
2015-05-05 | TEAS EXTENSION RECEIVED |
2015-05-05 | EXTENSION 5 FILED |
2015-05-05 | EXTENSION 5 GRANTED |
2015-05-07 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2015-05-14 | ASSIGNED TO PETITION STAFF |
2015-05-20 | PETITION TO DIRECTOR - CHANGE BASIS - GRANTED |
2015-05-26 | NOTICE OF ALLOWANCE CANCELLED |
2015-05-29 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
2015-06-24 | ELECTRONIC RECORD REVIEW COMPLETE |
2015-06-26 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
2015-06-30 | ELECTRONIC RECORD REVIEW COMPLETE |
2015-07-15 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2015-08-04 | PUBLISHED FOR OPPOSITION |
2015-08-04 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2015-10-20 | REGISTERED-PRINCIPAL REGISTER |
2020-10-20 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
2021-10-20 | TEAS SECTION 8 RECEIVED |
2021-10-27 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |